MedTrace Logo

Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer

NCT02693665 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2025-05-08

Study results available
· View outcomes & findings →

Summary

To test the efficacy of FACE-TC on key outcomes, the investigators propose using an intent-to-treat, longitudinal, prospective, multi-site, randomized controlled trial (RCT) design. Adolescents with cancer, aged 14 up to 20 years, and their families (N=130 dyads; N=260 participants) will be recruited and randomized to FACE-TC or Treatment as Usual (TAU) control. Participants will complete standardized questionnaires at baseline and 3, 6, 12, and 18 months post-intervention. Our goal is to assess the extent to which FACE-TC helps adolescents and young adults with cancer and their families: (1) reach and maintain better congruence in treatment preferences over time; (2) improve their quality of life; and (3) document goals of care and advance directives earlier in the course of their potentially life limiting illness.

Conditions

Interventions

BEHAVIORAL

FAmily CEntered Advance Care Planning for Teens with Cancer

3 session weekly intervention: 1) survey completed by adolescent and family (surrogate decision maker) separately with facilitator; 2) Respecting Choices structured interview about patient's representation of illness, goals of care, hopes, treatment preferences; 3) completion of an advance directive.

Sponsors & Collaborators

  • St. Jude Children's Research Hospital

    collaborator OTHER

  • Akron Children's Hospital

    collaborator OTHER

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • Masonic Cancer Center, University of Minnesota

    collaborator OTHER

  • Maureen Lyon

    lead OTHER

Principal Investigators

  • Maureen E Lyon, PhD · Children's National Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-16
Primary Completion
2021-04-30
Completion
2022-09-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02693665 on ClinicalTrials.gov